ClinicalTrials.gov
public full text
Public Domain
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD. For more information about the EMBRACE study, including participating study locations, and to register your interest in learning more about participation, please visit the study website: https://embrace-mdd-trial.com/
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Psilocybin for Major Depressive Disorder (MDD)#1165210
- PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)#1094826
- Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study.#445989
- Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder#906047
- Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)#1093531
Record · ID 1058862
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive